title: [Severe, bilateral vision loss in malignant melanoma of the skin. Anterior ischemic optic neuropathy with irreversible vision and visual field loss in adjuvant interferon alfa-2b therapy].
authors.affiliation: Augenklinik, Universität Regensburg. bernhard.gabler@klinik.uni-regensburg.de
authors.forename: B
authors.initials: B
authors.lastname: Gabler
authors.forename: G
authors.initials: G
authors.lastname: Kroher
authors.forename: T
authors.initials: T
authors.lastname: Bogenrieder
authors.forename: D
authors.initials: D
authors.lastname: Spiegel
authors.forename: J
authors.initials: J
authors.lastname: Preuner
authors.forename: C P
authors.initials: CP
authors.lastname: Lohmann
mesh_terms: D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005451:Fluorescein Angiography; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000601:surgery; D008875:Middle Aged; D018917:Optic Neuropathy, Ischemic / Q000139:chemically induced* / Q000175:diagnosis; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery; D015354:Vision, Low / Q000139:chemically induced* / Q000175:diagnosis; D014794:Visual Fields / Q000187:drug effects*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins